ALPHANOVUM BIO Trademark

Trademark Overview

On Saturday, June 20, 2026, a trademark application was filed for ALPHANOVUM BIO with the United States Patent and Trademark Office. The USPTO has given the ALPHANOVUM BIO trademark a serial number of 99896185. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, June 20, 2026. This trademark is owned by James P Tursi. The ALPHANOVUM BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development
alphanovum bio

General Information

Serial Number99896185
Word MarkALPHANOVUM BIO
Filing DateSaturday, June 20, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateSaturday, June 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Translation of Words in MarkNovum - Latin term meaning novel has no meaning in a foreign language.
Pseudo MarkALPHA NOVUM BIO
Goods and ServicesConsulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 20, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJames P Tursi
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNaples, FL 34114
US

Trademark Events

Event DateEvent Description
Saturday, June 20, 2026NEW APPLICATION ENTERED
Saturday, June 20, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

alphanovum research pharmaceutical field consulting services development